Press release
First-hand information, exhaustive and accurate, about our company
Capital Energy and ADL BioPharma sign a renewable energy provision contract and become strategic partners
Within the framework of both companies’ commitment to sustainable development Capital Energy will provide 61,000 megawatts hour (MWh) per year of clean and competitive power to this emblematic Leonese biotechnology company premises over the next five years....
ADL BioPharma renewed its “GMP food” certification
Last June, ADL BioPharma renewed its “GMP food” certification in compliance with the CODEX Alimentarius, for production through fermentation and recovery processes. In addition, it extends and certifies this quality system to its Fermentation Pilot Plant and the...
ADL’s pilot plant resumes its activity with two important projects
At the beginning of 2021 ADL resumed activity in the pilot plant in which the technology transfer of two projects is currently being carried out. One of them aims to produce a high-value product in the cosmetic industry, and the other focuses on the production of a...
ADL participates in CPhI Worldwide, the world’s most recognised pharmaceutical industry fair
In addition, they have also been present in the digital edition of the BIO International Convention, which brings together the main companies in the biotechnology sector. Between the 17th and 24th of May, ADL participated in the most important pharmaceutical industry...
ADL is committed to innovation and environmental sustainability in this new stage
The biotechnology company ADL BioPharma is committed to innovation and environmental sustainability as the basis for providing personalized, sustainable and reliable biotechnological solutions that facilitate companies, of any size, the manufacture of products that...
